When people learn about their disease risks through genetic testing, this information has the potential to impact their family members. Family members could share these genetic risks, and consequently could benefit from their own genetic risk assessment and testing, as well as from the adoption of preventive behaviors. Therefore, it is crucial that people effectively communicate their genetic test results to their at-risk family members, and that family members seek their own genetic testing (i.e., cascade testing). However, existing research confirms that communication and rates of cascade testing among families are frequently suboptimal. Our research investigates the experiences of family communication of genetic risk information, with the ultimate goals of developing and testing strategies to improve this process.
An example project is:
Effective Familial OutReach via Telegenetics (EfFORT) Study
Dr. Hamilton and her collaborator Dr. Kenneth Offit are leading an ongoing randomized controlled trial to improve levels of cascade testing among at-risk relatives of patients with a pathogenic variant in a cancer predisposition gene through use of a digital tool and direct provider outreach. Cascade genetic testing for a known hereditary cancer pathogenic variant reduces morbidity and mortality, and is cost-effective. Yet, patients and families face barriers to effectively completing cascade testing, and this project is evaluating a novel approach to facilitating this process.
- https://www.mskcc.org/cancer-care/risk-assessment-screening/genetic-counseling-and-testing/clinical-trials/effort-study
- Gruberg J, Groner V, Fanjoy C, Ongaro G, Green D, Trottier M, Polubriaginof FCG, Stadler ZK, Offit K, Hamilton JG. (2026, April). What factors determine patient use of a digital tool to increase family genetic testing for hereditary cancer syndromes? Poster presented at the Society of Behavioral Medicine annual meeting, Chicago, IL.